id000022
10.3205/id000022
urn:nbn:de:0183-id0000225
Research Article
suPAR remains uninfluenced by surgery in septic patients with bloodstream infection
Rabensteiner
Rabensteiner
Jasmin
J
MD
Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, AustriaClinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Austria
jasmin.rabensteiner@medunigraz.at
author
Prüller
Prüller
Florian
F
Priv.-Doz. Dr. Dr.med.univ.
Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Austria
florian.prueller@klinikum-graz.at
author
Prattes
Prattes
Jürgen
J
Dr.med.univ.
Section of Infectious Diseases and Tropical Medicine, Department of Internal Medicine, Medical University of Graz, Austria
juergen.prattes@medunigraz.at
author
Valentin
Valentin
Thomas
T
Dr.med.univ.
Section of Infectious Diseases and Tropical Medicine, Department of Internal Medicine, Medical University of Graz, Austria
thomas.valentin@klinikum-graz.at
author
Zollner-Schwetz
Zollner-Schwetz
Ines
I
Ass.Prof. Priv.-Doz. Dr. med.univ.
Section of Infectious Diseases and Tropical Medicine, Department of Internal Medicine, Medical University of Graz, Austria
ines.schwetz@medunigraz.at
author
Krause
Krause
Robert
R
Univ.-Prof. Dr.med.univ.
Section of Infectious Diseases and Tropical Medicine, Department of Internal Medicine, Medical University of Graz, Austria
robert.krause@medunigraz.at
author
Hoenigl
Hoenigl
Martin
M
Ass.-Arzt Priv.-Doz. Dr.med.univ.
Section of Infectious Diseases and Tropical Medicine, Department of Internal Medicine, Medical University of Graz, Austria
Division of Infectious Diseases, Department of Medicine, University of California, San Diego, CA, USA
martin.hoenigl@medunigraz.at
author
German Medical Science GMS Publishing House
Düsseldorf
610
sepsis biomarker
surgical intervention
soluble urokinase plasminogen activator receptor (suPAR)
procalcitonin (PCT)
interleukin-6 (IL-6)
C-reactive protein (CRP)
20160718
engl
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License.
Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung).
2195-8831
4
GMS Infectious Diseases
GMS Infect Dis
04
Surgical trauma induces activation of the immune system and may cause an increase of inflammatory biomarkers tested postoperatively in septic patients treated for bloodstream infection. The aim of this study was to determine the impact of surgical interventions on the novel sepsis biomarker soluble urokinase plasminogen activator receptor (suPAR) and to compare results with those of routine laboratory parameters CRP, PCT, and IL-6 in patients with culture-proven bloodstream infection. Forty-six adult patients with positive blood culture undergoing minor or major surgical intervention were investigated, 12 blood culture positive patients served as control group. Blood was collected 24 hours before and after surgical intervention for determination of the sepsis biomarkers suPAR, CRP, PCT, and IL-6. Within the surgical study cohort, a non-significant increase of suPAR, CRP, and PCT was observed postoperatively (p 0.642; p 0.773; p 0.087). In contrast, a slight decrease of IL-6 (p 0.599) was observed. A significant correlation was calculated for the pre- and postoperative difference of CRP (p 0.028) and PCT <![CDATA[(</PlainText><Mark2>p </Mark2><PlainText>0.008)</PlainText></TextGroup> and type of surgical intervention received: after minor surgical intervention only PCT decreased significantly (<Mark2>p</Mark2><0.001), while after major surgical interventions no significant differences were observed for all biomarkers evaluated. In the control group, a significant decrease of CRP (<Mark2>p</Mark2> 0.005) and PCT (<Mark2>p</Mark2> 0.005) was observed. In patients treated adequately for bloodstream infections, postoperative suPAR levels remained uninfluenced of the surgical trauma and might therefore be a reliable parameter for postoperative infectious monitoring. After minor surgical intervention, PCT seems to be the most reliable parameter.</Pgraph></Abstract>
<TextBlock linked="yes" name="Introduction">
<MainHeadline>Introduction</MainHeadline><Pgraph>Sepsis is a major health concern associated with significant morbidity and mortality <TextLink reference="1"></TextLink>, <TextLink reference="2"></TextLink>, <TextLink reference="3"></TextLink>. Different biomarkers are used for diagnosis and therapy monitoring of systemic infections, especially C-reactive protein (CRP), procalcitonin (PCT), and interleukin-6 (IL-6) <TextLink reference="4"></TextLink>, <TextLink reference="5"></TextLink>, <TextLink reference="6"></TextLink>. Antiinfective therapy monitoring becomes complicated once a patient has to undergo surgical interventions while being treated for bloodstream infection. It is well known that any surgical trauma causes local activation of various white blood cells, which release different cytokines and mediators for further activation of the immune system <TextLink reference="7"></TextLink>. Infectious complication is the most important differential diagnosis for a postoperative increase of biomarkers in septic patients. The decision whether or not to adapt/escalate the antiinfective regimen in patients with a postoperative increase of biomarkers or to choose a “wait-and-see” strategy with further monitoring of biomarkers therefore remains a challenge. In patients with increasing sepsis biomarkers after surgery a possible iatrogenic driven elevation of these markers due to the surgical trauma per se may lead to misinterpretation of test results and hence of the clinical patient’s condition.</Pgraph><Pgraph>The aim of this study was to determine the impact of surgical interventions on the novel sepsis biomarker soluble urokinase plasminogen activator receptor (suPAR) <TextLink reference="4"></TextLink>, <TextLink reference="6"></TextLink>, <TextLink reference="8"></TextLink>, <TextLink reference="9"></TextLink> and to compare with the routinely used laboratory parameters CRP, PCT, and IL-6 in patients with culture-proven bloodstream infection.</Pgraph></TextBlock>
<TextBlock linked="yes" name="Methods">
<MainHeadline>Methods</MainHeadline><Pgraph>This retrospective analysis of a cohort study evaluated patients who were enrolled into the NOBIS study <TextGroup><PlainText>(ClinicalTrials.gov</PlainText></TextGroup> Identifier: NCT01359891) between May 2011 and July 2012 at the University Hospital Graz, Austria. Study samples were collected as part of the participation in the NOBIS study, which enrolled more than 700 patients with bloodstream infection <TextLink reference="4"></TextLink>, <TextLink reference="5"></TextLink>, <TextLink reference="6"></TextLink>. For participation to the NOBIS study informed consent was required prior to sample collection. The objective of this analysis was to evaluate the impact of surgery on inflammatory biomarkers in patients treated adequately for bloodstream infection.</Pgraph><Pgraph>NOBIS participants with culture-proven bacteremia were included in this analysis if they met the following inclusion criteria: (i) age above 18 years, (ii) presentation at or admitted to the University Hospital of Graz, Austria, (iii) fulfillment of systemic inflammatory response syndrome criteria and clinical suspicion of bacteremia/septicemia by the attending physician, (iv) positive result of drawn blood culture, (v) surgical intervention in the following ten days after initial positive blood culture, (vi) blood sample within 24 hours before and after surgical intervention, (vii) absence of local, organic and systemic infectious complications until seven postoperative days, and (viii) informed consent. </Pgraph><Pgraph>A total of 58 patients met the inclusion criteria. Patients’ medical records were reviewed by using a standardized data collection template in order to collect demographic information and clinical data. Type of surgical intervention and laboratory test results for CRP, PCT, suPAR and IL-6, as well as microbiological results were extracted from computerized databases. </Pgraph><Pgraph>Fourty-six patients with positive blood culture result were included and two different groups of surgical interventions were defined: minor and major (Table 1 <ImgLink imgNo="1" imgType="table"/>). Minor surgical interventions were classified as invasive interventions with minimal or low tissue damage; and major surgical interventions were defined as operations with high amount of tissue damage, e.g. liver transplantation or open valve repair surgery. Another 12 patients with positive blood culture, and subsequent surgical intervention of implantation or explantation of central venous access served as the control group (Table 1 <ImgLink imgNo="1" imgType="table"/>). All 58 patients received adequate antibiotic or antifungal therapy according to the susceptibility testing of the microbiological laboratory. This study was approved by the ethics committee of the Medical University of Graz, Austria (EC-number 21–469 ex 09/10).</Pgraph><Pgraph>Three pairs of blood culture bottles (BACTEC™ Plus Aerobic/F and Anaerobic/F) were drawn from each patient and incubated in the continuously monitored blood culture instrument BD BACTEC™ FX (BD Diagnostics, Sparks, MD). Positive blood cultures were further processed; microbiological identifications of responsible pathogens were performed by routine laboratory measures in the Microbiological Laboratory, Medical University Graz. Detailed results of determined pathogens are displayed in Table 2 <ImgLink imgNo="2" imgType="table"/>.</Pgraph><Pgraph>Lithium heparin plasma samples were obtained for testing CRP, PCT, and IL-6 immediately after blood collection on a fully automated laboratory analyzer (Cobas 8000 system, Roche Diagnostics, Rotkreuz, Switzerland). Determination of suPAR was performed from EDTA plasma samples which were immediately stored at –80°C after blood collection using the suPARnostic™ ELISA kit (ViroGates, Copenhagen, Denmark) according to the manufactures instructions. Measurements were <TextGroup><PlainText>performed</PlainText></TextGroup> at the Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University Graz, on an ELISA platform reader (Flex Station 3, Molecular Devices, Munich, Germany).</Pgraph><Pgraph>Statistical analysis was performed using SPSS, version 21 (SPSS Inc., Chicago, IL, USA). Continuous data (<Mark2>e.g.</Mark2> suPAR values) are presented as medians with interquartile ranges (IQR) or means (± standard deviation), and categorical data as proportions. A <Mark2>p</Mark2>-value of less than 0.05 was considered statistically significant, using <TextGroup><PlainText>Wilcoxon</PlainText></TextGroup> test. Correlation was calculated using Spearman-Rho calculation analysis. We performed a sample size calculation for the comparison of pre- and postoperative suPAR levels for the two groups undergoing surgery using paired t-test and powered the study for detection of an effect size that corresponds to a standardized effect size of 0.65, assuming normal data. When alpha (two sided) =0.05 and power=0.80, 21 patients need to be included per group, with pre- and postoperative suPAR levels available. The control group was powered for detection of a standardized effect size of 0.9.</Pgraph></TextBlock>
<TextBlock linked="yes" name="Results">
<MainHeadline>Results</MainHeadline><Pgraph>No significant correlation was found between the number of blood culture positive days before surgical intervention (median 3 days, range 0–10) and the difference of pre- and postoperative suPAR, CRP, PCT, and IL-6 levels.</Pgraph><Pgraph>Within the whole study cohort, no significant change of suPAR (<Mark2>p</Mark2> 0.642), CRP (<Mark2>p</Mark2> 0.773), PCT (<Mark2>p</Mark2> 0.087), and IL-6 (<Mark2>p</Mark2> 0.599) was observed postoperatively (Table 3 <ImgLink imgNo="3" imgType="table"/>). </Pgraph><Pgraph>In the control group, a significant decrease of CRP <TextGroup><PlainText>(</PlainText><Mark2>p</Mark2><PlainText> 0.005)</PlainText></TextGroup> and PCT (<Mark2>p</Mark2> 0.005) was observed, while suPAR <TextGroup><PlainText>(</PlainText><Mark2>p</Mark2><PlainText> 0.071)</PlainText></TextGroup> and IL-6 (<Mark2>p</Mark2> 0.239) did not decrease significantly (Table 4 <ImgLink imgNo="4" imgType="table"/>). In patients receiving minor surgical interventions, only PCT (<Mark2>p</Mark2><0.001) showed a significant postoperative decrease, whereas for suPAR (<Mark2>p</Mark2> 0.783), CRP <TextGroup><PlainText>(</PlainText><Mark2>p</Mark2><PlainText> 0.375)</PlainText></TextGroup>, and IL-6 (<Mark2>p</Mark2> 0.543) no significant change was calculated (Table 4 <ImgLink imgNo="4" imgType="table"/>). In patients with major surgical interventions no postoperative de- or increase of suPAR <TextGroup><PlainText>(</PlainText><Mark2>p</Mark2><PlainText> 0.407)</PlainText></TextGroup>, CRP (<Mark2>p</Mark2> 0.530), PCT (<Mark2>p</Mark2> 0.209), and IL-6 <TextGroup><PlainText>(</PlainText><Mark2>p</Mark2><PlainText> 0.855)</PlainText></TextGroup> was observed (Table 4 <ImgLink imgNo="4" imgType="table"/>). When differences between the pre- and postoperative levels of the 4 biomarkers suPAR, CRP, PCT, and IL-6 were analyzed according to the 3 different groups of surgical intervention (minor, major, and control), a significant correlation was calculated for CRP (<Mark2>p</Mark2> 0.028) and PCT (<Mark2>p</Mark2> 0.008).</Pgraph></TextBlock>
<TextBlock linked="yes" name="Discussion">
<MainHeadline>Discussion</MainHeadline><Pgraph>In this study, the impact of tissue damage due to surgical interventions on the sepsis biomarkers suPAR, CRP, PCT, and IL-6 in patients treated for culture-proven bloodstream infection was investigated. </Pgraph><Pgraph>In patients with increasing sepsis biomarkers after surgery a possible iatrogenic driven elevation of these markers due to the surgical trauma <Mark2>per se</Mark2> may lead to <TextGroup><PlainText>misinterpretation</PlainText></TextGroup> of test results and hence of the clinical patient’s condition. Surgical trauma can induce an increase of CRP and IL-6 levels strongly depending on the size of local tissue damage <TextLink reference="10"></TextLink>, <TextLink reference="11"></TextLink>, <TextLink reference="12"></TextLink>. Previous studies have reported that IL-6, after reaching the peak immediately after surgical intervention decreases rapidly during the first postoperative day <TextLink reference="13"></TextLink>. PCT is mainly stimulated by bacterial endotoxins and might therefore be a more suitable and specific parameter for the early postoperative period <TextLink reference="14"></TextLink>, <TextLink reference="15"></TextLink>. SuPAR has proven to be a useful <TextGroup><PlainText>parameter</PlainText></TextGroup> to predict bacteremia in patients presenting with systemic inflammatory response syndrome <TextLink reference="4"></TextLink>, <TextLink reference="16"></TextLink>. High suPAR levels on the first postoperative day may be therefore of special interest. </Pgraph><Pgraph>In this study, suPAR, CRP, and IL-6 remained on a steady level in the early postoperative phase in patients receiving minor but also major surgery. These results suggest that suPAR remains uninfluenced by surgical trauma <Mark2>per se</Mark2> and therefore seem to be a possible parameter for diagnosing early postoperative infectious complications. Similar results were reported by Gozdzik and colleagues. SuPAR plasma levels remained stable in patients undergoing elective coronary bypass graft surgery under cardiopulmonary bypass. No significant changes were determined either 6 or 24 hours postoperatively <TextLink reference="17"></TextLink>. Svendsen et al. also revealed that high concentrations of suPAR are significantly associated with the development of postoperative pneumonia after elective surgery for colorectal cancer <TextLink reference="18"></TextLink>.</Pgraph><Pgraph>PCT showed a significant postoperative decrease after minor surgical intervention and in the control group. According to the literature, PCT seems to be a useful, independent parameter for detection of infectious postoperative complications, especially at the postoperative <TextGroup><PlainText>day 1</PlainText></TextGroup> and can also be used for postoperative monitoring for antiinfective therapy <TextLink reference="19"></TextLink>, <TextLink reference="20"></TextLink>. CRP showed a significant decrease only in the control group. Therefore we suggest that especially after minor surgical interventions, PCT is the most reliable parameter for early postoperative infectious complications. After major surgical intervention no parameter of the 4 tested was superior and therefore no suggestion can be made. Since currently suPAR is only used for research use, the remaining three biomarkers CRP, PCT, and IL-6 have to be used in the routine, all showing equal diagnostic potential to suPAR.</Pgraph><Pgraph>This study design also has some limitations, in particular numbers of patients were small for the different types of surgical interventions.</Pgraph></TextBlock>
<TextBlock linked="yes" name="Conclusions">
<MainHeadline>Conclusions</MainHeadline><Pgraph>In conclusion suPAR remained on a steady level in the early postoperative phase and seems not to be influenced by the local tissue damage in patients receiving minor or major surgical intervention. PCT was the most reliable parameter for early postoperative infectious monitoring after minor surgical interventions, while after major surgical intervention none of the four parameters tested was shown to be superior regarding diagnostic potential.</Pgraph><SubHeadline>Key Messages</SubHeadline><Pgraph><OrderedList><ListItem level="1" levelPosition="1" numString="1.">Surgical trauma <Mark2>per se</Mark2> may lead to an iatrogenic driven elevation of sepsis biomarkers due to local tissue damage.</ListItem><ListItem level="1" levelPosition="2" numString="2.">Postoperative suPAR levels remained uninfluenced irrespective of type of surgery.</ListItem><ListItem level="1" levelPosition="3" numString="3.">PCT showed a significant decrease in patients receiving minor surgery and in the control group.</ListItem></OrderedList></Pgraph></TextBlock>
<TextBlock linked="yes" name="Abbreviations">
<MainHeadline>Abbreviations</MainHeadline><Pgraph><UnorderedList><ListItem level="1">CRP – C-reactive protein</ListItem><ListItem level="1">IL-6 – interleukin-6</ListItem><ListItem level="1">IQR – interquartile ranges</ListItem><ListItem level="1">PCT – procalcitonin</ListItem><ListItem level="1">suPAR – soluble urokinase plasminogen activator receptor</ListItem></UnorderedList></Pgraph></TextBlock>
<TextBlock linked="yes" name="Notes">
<MainHeadline>Notes</MainHeadline><SubHeadline>Study registration</SubHeadline><Pgraph>ClinicalTrials.gov Identifier: NCT01359891</Pgraph><Pgraph>Registration date: May 23, 2011</Pgraph><SubHeadline>Acknowledgments</SubHeadline><Pgraph>The authors thank Christina Strempfl, Bernadette Neuhold, and Verena Posch for their support in the microbiologic laboratory and Elisabeth Winter for performing suPAR assays for discussion of results.</Pgraph><SubHeadline>Conflicts of interest</SubHeadline><Pgraph>SuPAR kits used in the study were provided by the companies’ suPARnostic (Kopenhagen, Denmark) and Biomedica Medical Products (Vienna, Austria). No other funding was obtained.</Pgraph><Pgraph>The authors declare no conflict of interest.</Pgraph></TextBlock>
<References linked="yes">
<Reference refNo="1">
<RefAuthor>Hotchkiss RS</RefAuthor>
<RefAuthor>Karl IE</RefAuthor>
<RefTitle>The pathophysiology and treatment of sepsis</RefTitle>
<RefYear>2003</RefYear>
<RefJournal>N Engl J Med</RefJournal>
<RefPage>138-50</RefPage>
<RefTotal>Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003 Jan;348(2):138-50. DOI: 10.1056/NEJMra021333</RefTotal>
<RefLink>http://dx.doi.org/10.1056/NEJMra021333</RefLink>
</Reference>
<Reference refNo="2">
<RefAuthor>Angus DC</RefAuthor>
<RefAuthor>van der Poll T</RefAuthor>
<RefTitle>Severe sepsis and septic shock</RefTitle>
<RefYear>2013</RefYear>
<RefJournal>N Engl J Med</RefJournal>
<RefPage>2063</RefPage>
<RefTotal>Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013 Nov;369(21):2063. DOI: 10.1056/NEJMc1312359</RefTotal>
<RefLink>http://dx.doi.org/10.1056/NEJMc1312359</RefLink>
</Reference>
<Reference refNo="3">
<RefAuthor>Singer M</RefAuthor>
<RefAuthor>Deutschman CS</RefAuthor>
<RefAuthor>Seymour CW</RefAuthor>
<RefAuthor>Shankar-Hari M</RefAuthor>
<RefAuthor>Annane D</RefAuthor>
<RefAuthor>Bauer M</RefAuthor>
<RefAuthor>Bellomo R</RefAuthor>
<RefAuthor>Bernard GR</RefAuthor>
<RefAuthor>Chiche JD</RefAuthor>
<RefAuthor>Coopersmith CM</RefAuthor>
<RefAuthor>Hotchkiss RS</RefAuthor>
<RefAuthor>Levy MM</RefAuthor>
<RefAuthor>Marshall JC</RefAuthor>
<RefAuthor>Martin GS</RefAuthor>
<RefAuthor>Opal SM</RefAuthor>
<RefAuthor>Rubenfeld GD</RefAuthor>
<RefAuthor>van der Poll T</RefAuthor>
<RefAuthor>Vincent JL</RefAuthor>
<RefAuthor>Angus DC</RefAuthor>
<RefTitle>The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)</RefTitle>
<RefYear>2016</RefYear>
<RefJournal>JAMA</RefJournal>
<RefPage>801-10</RefPage>
<RefTotal>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016 Feb;315(8):801-10. DOI: 10.1001/jama.2016.0287</RefTotal>
<RefLink>http://dx.doi.org/10.1001/jama.2016.0287</RefLink>
</Reference>
<Reference refNo="4">
<RefAuthor>Hoenigl M</RefAuthor>
<RefAuthor>Raggam RB</RefAuthor>
<RefAuthor>Wagner J</RefAuthor>
<RefAuthor>Valentin T</RefAuthor>
<RefAuthor>Leitner E</RefAuthor>
<RefAuthor>Seeber K</RefAuthor>
<RefAuthor>Zollner-Schwetz I</RefAuthor>
<RefAuthor>Krammer W</RefAuthor>
<RefAuthor>Prüller F</RefAuthor>
<RefAuthor>Grisold AJ</RefAuthor>
<RefAuthor>Krause R</RefAuthor>
<RefTitle>Diagnostic accuracy of soluble urokinase plasminogen activator receptor (suPAR) for prediction of bacteremia in patients with systemic inflammatory response syndrome</RefTitle>
<RefYear>2013</RefYear>
<RefJournal>Clin Biochem</RefJournal>
<RefPage>225-9</RefPage>
<RefTotal>Hoenigl M, Raggam RB, Wagner J, Valentin T, Leitner E, Seeber K, Zollner-Schwetz I, Krammer W, Prüller F, Grisold AJ, Krause R. Diagnostic accuracy of soluble urokinase plasminogen activator receptor (suPAR) for prediction of bacteremia in patients with systemic inflammatory response syndrome. Clin Biochem. 2013 Feb;46(3):225-9. DOI: 10.1016/j.clinbiochem.2012.11.004</RefTotal>
<RefLink>http://dx.doi.org/10.1016/j.clinbiochem.2012.11.004</RefLink>
</Reference>
<Reference refNo="5">
<RefAuthor>Rabensteiner J</RefAuthor>
<RefAuthor>Skvarc M</RefAuthor>
<RefAuthor>Hoenigl M</RefAuthor>
<RefAuthor>Osredkar J</RefAuthor>
<RefAuthor>Prueller F</RefAuthor>
<RefAuthor>Reichsoellner M</RefAuthor>
<RefAuthor>Krause R</RefAuthor>
<RefAuthor>Raggam RB</RefAuthor>
<RefTitle>Diagnostic and prognostic potential of presepsin in Emergency Department patients presenting with systemic inflammatory response syndrome</RefTitle>
<RefYear>2014</RefYear>
<RefJournal>J Infect</RefJournal>
<RefPage>627-30</RefPage>
<RefTotal>Rabensteiner J, Skvarc M, Hoenigl M, Osredkar J, Prueller F, Reichsoellner M, Krause R, Raggam RB. Diagnostic and prognostic potential of presepsin in Emergency Department patients presenting with systemic inflammatory response syndrome. J Infect. 2014 Dec;69(6):627-30. DOI: 10.1016/j.jinf.2014.07.024</RefTotal>
<RefLink>http://dx.doi.org/10.1016/j.jinf.2014.07.024</RefLink>
</Reference>
<Reference refNo="6">
<RefAuthor>Raggam RB</RefAuthor>
<RefAuthor>Wagner J</RefAuthor>
<RefAuthor>Prüller F</RefAuthor>
<RefAuthor>Grisold A</RefAuthor>
<RefAuthor>Leitner E</RefAuthor>
<RefAuthor>Zollner-Schwetz I</RefAuthor>
<RefAuthor>Valentin T</RefAuthor>
<RefAuthor>Krause R</RefAuthor>
<RefAuthor>Hoenigl M</RefAuthor>
<RefTitle>Soluble urokinase plasminogen activator receptor predicts mortality in patients with systemic inflammatory response syndrome</RefTitle>
<RefYear>2014</RefYear>
<RefJournal>J Intern Med</RefJournal>
<RefPage>651-8</RefPage>
<RefTotal>Raggam RB, Wagner J, Prüller F, Grisold A, Leitner E, Zollner-Schwetz I, Valentin T, Krause R, Hoenigl M. Soluble urokinase plasminogen activator receptor predicts mortality in patients with systemic inflammatory response syndrome. J Intern Med. 2014 Dec;276(6):651-8. DOI: 10.1111/joim.12238</RefTotal>
<RefLink>http://dx.doi.org/10.1111/joim.12238</RefLink>
</Reference>
<Reference refNo="7">
<RefAuthor>Fornara P</RefAuthor>
<RefAuthor>Doehn C</RefAuthor>
<RefAuthor>Seyfarth M</RefAuthor>
<RefAuthor>Jocham D</RefAuthor>
<RefTitle>Why is urological laparoscopy minimally invasive? Eur Urol</RefTitle>
<RefYear>2000</RefYear>
<RefTotal>Fornara P, Doehn C, Seyfarth M, Jocham D. Why is urological laparoscopy minimally invasive? Eur Urol. 2000 Mar;37(3):241-50. DOI: 10.1159/000052351</RefTotal>
<RefLink>http://dx.doi.org/10.1159/000052351</RefLink>
</Reference>
<Reference refNo="8">
<RefAuthor>Donadello K</RefAuthor>
<RefAuthor>Scolletta S</RefAuthor>
<RefAuthor>Covajes C</RefAuthor>
<RefAuthor>Vincent JL</RefAuthor>
<RefTitle>suPAR as a prognostic biomarker in sepsis</RefTitle>
<RefYear>2012</RefYear>
<RefJournal>BMC Med</RefJournal>
<RefPage>2</RefPage>
<RefTotal>Donadello K, Scolletta S, Covajes C, Vincent JL. suPAR as a prognostic biomarker in sepsis. BMC Med. 2012;10:2. DOI: 10.1186/1741-7015-10-2</RefTotal>
<RefLink>http://dx.doi.org/10.1186/1741-7015-10-2</RefLink>
</Reference>
<Reference refNo="9">
<RefAuthor>Backes Y</RefAuthor>
<RefAuthor>van der Sluijs KF</RefAuthor>
<RefAuthor>Mackie DP</RefAuthor>
<RefAuthor>Tacke F</RefAuthor>
<RefAuthor>Koch A</RefAuthor>
<RefAuthor>Tenhunen JJ</RefAuthor>
<RefAuthor>Schultz MJ</RefAuthor>
<RefTitle>Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic review</RefTitle>
<RefYear>2012</RefYear>
<RefJournal>Intensive Care Med</RefJournal>
<RefPage>1418-28</RefPage>
<RefTotal>Backes Y, van der Sluijs KF, Mackie DP, Tacke F, Koch A, Tenhunen JJ, Schultz MJ. Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic review. Intensive Care Med. 2012 Sep;38(9):1418-28. DOI: 10.1007/s00134-012-2613-1</RefTotal>
<RefLink>http://dx.doi.org/10.1007/s00134-012-2613-1</RefLink>
</Reference>
<Reference refNo="10">
<RefAuthor>Oberhofer D</RefAuthor>
<RefAuthor>Juras J</RefAuthor>
<RefAuthor>Pavicić AM</RefAuthor>
<RefAuthor>Rancić Zurić I</RefAuthor>
<RefAuthor>Rumenjak V</RefAuthor>
<RefTitle>Comparison of C-reactive protein and procalcitonin as predictors of postoperative infectious complications after elective colorectal surgery</RefTitle>
<RefYear>2012</RefYear>
<RefJournal>Croat Med J</RefJournal>
<RefPage>612-9</RefPage>
<RefTotal>Oberhofer D, Juras J, Pavicić AM, Rancić Zurić I, Rumenjak V. Comparison of C-reactive protein and procalcitonin as predictors of postoperative infectious complications after elective colorectal surgery. Croat Med J. 2012 Dec;53(6):612-9. DOI: 10.3325/cmj.2012.53.612</RefTotal>
<RefLink>http://dx.doi.org/10.3325/cmj.2012.53.612</RefLink>
</Reference>
<Reference refNo="11">
<RefAuthor>Lindberg M</RefAuthor>
<RefAuthor>Hole A</RefAuthor>
<RefAuthor>Johnsen H</RefAuthor>
<RefAuthor>Asberg A</RefAuthor>
<RefAuthor>Rydning A</RefAuthor>
<RefAuthor>Myrvold HE</RefAuthor>
<RefAuthor>Bjerve KS</RefAuthor>
<RefTitle>Reference intervals for procalcitonin and C-reactive protein after major abdominal surgery</RefTitle>
<RefYear>2002</RefYear>
<RefJournal>Scand J Clin Lab Invest</RefJournal>
<RefPage>189-94</RefPage>
<RefTotal>Lindberg M, Hole A, Johnsen H, Asberg A, Rydning A, Myrvold HE, Bjerve KS. Reference intervals for procalcitonin and C-reactive protein after major abdominal surgery. Scand J Clin Lab Invest. 2002;62(3):189-94. DOI: 10.1080/003655102317475443</RefTotal>
<RefLink>http://dx.doi.org/10.1080/003655102317475443</RefLink>
</Reference>
<Reference refNo="12">
<RefAuthor>Wong K</RefAuthor>
<RefAuthor>Shahab Y</RefAuthor>
<RefAuthor>Gill PG</RefAuthor>
<RefTitle>Diagnostic value of an initial C-reactive protein level in acute surgical patients</RefTitle>
<RefYear>2012</RefYear>
<RefJournal>ANZ J Surg</RefJournal>
<RefPage>52-5</RefPage>
<RefTotal>Wong K, Shahab Y, Gill PG. Diagnostic value of an initial C-reactive protein level in acute surgical patients. ANZ J Surg. 2012 Jan-Feb;82(1-2):52-5. DOI: 10.1111/j.1445-2197.2011.05668.x</RefTotal>
<RefLink>http://dx.doi.org/10.1111/j.1445-2197.2011.05668.x</RefLink>
</Reference>
<Reference refNo="13">
<RefAuthor>Narita S</RefAuthor>
<RefAuthor>Tsuchiya N</RefAuthor>
<RefAuthor>Kumazawa T</RefAuthor>
<RefAuthor>Maita S</RefAuthor>
<RefAuthor>Numakura K</RefAuthor>
<RefAuthor>Obara T</RefAuthor>
<RefAuthor>Tsuruta H</RefAuthor>
<RefAuthor>Saito M</RefAuthor>
<RefAuthor>Inoue T</RefAuthor>
<RefAuthor>Horikawa Y</RefAuthor>
<RefAuthor>Satoh S</RefAuthor>
<RefAuthor>Habuchi T</RefAuthor>
<RefTitle>Comparison of surgical stress in patients undergoing open versus laparoscopic radical prostatectomy by measuring perioperative serum cytokine levels</RefTitle>
<RefYear>2013</RefYear>
<RefJournal>J Laparoendosc Adv Surg Tech A</RefJournal>
<RefPage>33-7</RefPage>
<RefTotal>Narita S, Tsuchiya N, Kumazawa T, Maita S, Numakura K, Obara T, Tsuruta H, Saito M, Inoue T, Horikawa Y, Satoh S, Habuchi T. Comparison of surgical stress in patients undergoing open versus laparoscopic radical prostatectomy by measuring perioperative serum cytokine levels. J Laparoendosc Adv Surg Tech A. 2013 Jan;23(1):33-7. DOI: 10.1089/lap.2012.0348</RefTotal>
<RefLink>http://dx.doi.org/10.1089/lap.2012.0348</RefLink>
</Reference>
<Reference refNo="14">
<RefAuthor>Dandona P</RefAuthor>
<RefAuthor>Nix D</RefAuthor>
<RefAuthor>Wilson MF</RefAuthor>
<RefAuthor>Aljada A</RefAuthor>
<RefAuthor>Love J</RefAuthor>
<RefAuthor>Assicot M</RefAuthor>
<RefAuthor>Bohuon C</RefAuthor>
<RefTitle>Procalcitonin increase after endotoxin injection in normal subjects</RefTitle>
<RefYear>1994</RefYear>
<RefJournal>J Clin Endocrinol Metab</RefJournal>
<RefPage>1605-8</RefPage>
<RefTotal>Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M, Bohuon C. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab. 1994 Dec;79(6):1605-8. DOI: 10.1210/jcem.79.6.7989463</RefTotal>
<RefLink>http://dx.doi.org/10.1210/jcem.79.6.7989463</RefLink>
</Reference>
<Reference refNo="15">
<RefAuthor>Meisner M</RefAuthor>
<RefAuthor>Tschaikowsky K</RefAuthor>
<RefAuthor>Hutzler A</RefAuthor>
<RefAuthor>Schick C</RefAuthor>
<RefAuthor>Schüttler J</RefAuthor>
<RefTitle>Postoperative plasma concentrations of procalcitonin after different types of surgery</RefTitle>
<RefYear>1998</RefYear>
<RefJournal>Intensive Care Med</RefJournal>
<RefPage>680-4</RefPage>
<RefTotal>Meisner M, Tschaikowsky K, Hutzler A, Schick C, Schüttler J. Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med. 1998 Jul;24(7):680-4. DOI: 10.1007/s001340050644</RefTotal>
<RefLink>http://dx.doi.org/10.1007/s001340050644</RefLink>
</Reference>
<Reference refNo="16">
<RefAuthor>Henic E</RefAuthor>
<RefAuthor>Borgfeldt C</RefAuthor>
<RefAuthor>Christensen IJ</RefAuthor>
<RefAuthor>Casslén B</RefAuthor>
<RefAuthor>Høyer-Hansen G</RefAuthor>
<RefTitle>Cleaved forms of the urokinase plasminogen activator receptor in plasma have diagnostic potential and predict postoperative survival in patients with ovarian cancer</RefTitle>
<RefYear>2008</RefYear>
<RefJournal>Clin Cancer Res</RefJournal>
<RefPage>5785-93</RefPage>
<RefTotal>Henic E, Borgfeldt C, Christensen IJ, Casslén B, Høyer-Hansen G. Cleaved forms of the urokinase plasminogen activator receptor in plasma have diagnostic potential and predict postoperative survival in patients with ovarian cancer. Clin Cancer Res. 2008 Sep;14(18):5785-93. DOI: 10.1158/1078-0432.CCR-08-0096</RefTotal>
<RefLink>http://dx.doi.org/10.1158/1078-0432.CCR-08-0096</RefLink>
</Reference>
<Reference refNo="17">
<RefAuthor>Gozdzik W</RefAuthor>
<RefAuthor>Adamik B</RefAuthor>
<RefAuthor>Gozdzik A</RefAuthor>
<RefAuthor>Rachwalik M</RefAuthor>
<RefAuthor>Kustrzycki W</RefAuthor>
<RefAuthor>Kübler A</RefAuthor>
<RefTitle>Unchanged plasma levels of the soluble urokinase plasminogen activator receptor in elective coronary artery bypass graft surgery patients and cardiopulmonary bypass use</RefTitle>
<RefYear>2014</RefYear>
<RefJournal>PLoS ONE</RefJournal>
<RefPage>e98923</RefPage>
<RefTotal>Gozdzik W, Adamik B, Gozdzik A, Rachwalik M, Kustrzycki W, Kübler A. Unchanged plasma levels of the soluble urokinase plasminogen activator receptor in elective coronary artery bypass graft surgery patients and cardiopulmonary bypass use. PLoS ONE. 2014;9(6):e98923. DOI: 10.1371/journal.pone.0098923</RefTotal>
<RefLink>http://dx.doi.org/10.1371/journal.pone.0098923</RefLink>
</Reference>
<Reference refNo="18">
<RefAuthor>Svendsen MN</RefAuthor>
<RefAuthor>Ytting H</RefAuthor>
<RefAuthor>Brünner N</RefAuthor>
<RefAuthor>Nielsen HJ</RefAuthor>
<RefAuthor>Christensen IJ</RefAuthor>
<RefTitle>Preoperative concentrations of suPAR and MBL proteins are associated with the development of pneumonia after elective surgery for colorectal cancer</RefTitle>
<RefYear>2006</RefYear>
<RefJournal>Surg Infect (Larchmt)</RefJournal>
<RefPage>463-71</RefPage>
<RefTotal>Svendsen MN, Ytting H, Brünner N, Nielsen HJ, Christensen IJ. Preoperative concentrations of suPAR and MBL proteins are associated with the development of pneumonia after elective surgery for colorectal cancer. Surg Infect (Larchmt). 2006 Oct;7(5):463-71. DOI: 10.1089/sur.2006.7.463</RefTotal>
<RefLink>http://dx.doi.org/10.1089/sur.2006.7.463</RefLink>
</Reference>
<Reference refNo="19">
<RefAuthor>Uzzan B</RefAuthor>
<RefAuthor>Cohen R</RefAuthor>
<RefAuthor>Nicolas P</RefAuthor>
<RefAuthor>Cucherat M</RefAuthor>
<RefAuthor>Perret GY</RefAuthor>
<RefTitle>Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis</RefTitle>
<RefYear>2006</RefYear>
<RefJournal>Crit Care Med</RefJournal>
<RefPage>1996-2003</RefPage>
<RefTotal>Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med. 2006 Jul;34(7):1996-2003. DOI: 10.1097/01.CCM.0000226413.54364.36</RefTotal>
<RefLink>http://dx.doi.org/10.1097/01.CCM.0000226413.54364.36</RefLink>
</Reference>
<Reference refNo="20">
<RefAuthor>Lee SH</RefAuthor>
<RefAuthor>Chan RC</RefAuthor>
<RefAuthor>Wu JY</RefAuthor>
<RefAuthor>Chen HW</RefAuthor>
<RefAuthor>Chang SS</RefAuthor>
<RefAuthor>Lee CC</RefAuthor>
<RefTitle>Diagnostic value of procalcitonin for bacterial infection in elderly patients - a systemic review and meta-analysis</RefTitle>
<RefYear>2013</RefYear>
<RefJournal>Int J Clin Pract</RefJournal>
<RefPage>1350-7</RefPage>
<RefTotal>Lee SH, Chan RC, Wu JY, Chen HW, Chang SS, Lee CC. Diagnostic value of procalcitonin for bacterial infection in elderly patients - a systemic review and meta-analysis. Int J Clin Pract. 2013 Dec;67(12):1350-7. DOI: 10.1111/ijcp.12278</RefTotal>
<RefLink>http://dx.doi.org/10.1111/ijcp.12278</RefLink>
</Reference>
</References>
<Media>
<Tables>
<Table format="png">
<MediaNo>1</MediaNo>
<MediaID>1</MediaID>
<Caption><Pgraph><Mark1>Table 1: Baseline characteristics of the study cohort (</Mark1><Mark1><Mark2>n</Mark2></Mark1><Mark1>=58). Baseline characteristics (mean ± standard deviation, number </Mark1><Mark1><Mark2>n</Mark2></Mark1><Mark1> and proportion in %), including type of surgical intervention.</Mark1></Pgraph></Caption>
</Table>
<Table format="png">
<MediaNo>2</MediaNo>
<MediaID>2</MediaID>
<Caption><Pgraph><Mark1>Table 2: Microbiological spectrum of blood stream infections. Detailed information about bacteria and fungi (number </Mark1><Mark1><Mark2>n</Mark2></Mark1><Mark1> and proportion in %) responsible for bloodstream infection. No significant difference between the groups was found in the microbiological spectrum (</Mark1><Mark1><Mark2>p</Mark2></Mark1><Mark1> 0.241).</Mark1></Pgraph></Caption>
</Table>
<Table format="png">
<MediaNo>3</MediaNo>
<MediaID>3</MediaID>
<Caption><Pgraph><Mark1>Table 3: Pre- and postoperative levels of biomarkers. Results of the tested parameters suPAR, CRP, PCT, and IL-6 levels (median and IQR) pre- and postoperative, displayed for the total surgical intervention study cohort (</Mark1><Mark1><Mark2>n</Mark2></Mark1><Mark1>=46). </Mark1></Pgraph></Caption>
</Table>
<Table format="png">
<MediaNo>4</MediaNo>
<MediaID>4</MediaID>
<Caption><Pgraph><Mark1>Table 4: Pre- and postoperative levels of biomarkers based on type of surgical intervention. SuPAR, CRP, PCT, and IL-6 levels (median and IQR) pre- and postoperative and </Mark1><Mark1><Mark2>p</Mark2></Mark1><Mark1>-values displayed for subgroups receiving minor (</Mark1><Mark1><Mark2>n</Mark2></Mark1><Mark1>=22), major surgical interventions (</Mark1><Mark1><Mark2>n</Mark2></Mark1><Mark1>=24) and control group (</Mark1><Mark1><Mark2>n</Mark2></Mark1><Mark1>=12).</Mark1></Pgraph></Caption>
</Table>
<NoOfTables>4</NoOfTables>
</Tables>
<Figures>
<NoOfPictures>0</NoOfPictures>
</Figures>
<InlineFigures>
<NoOfPictures>0</NoOfPictures>
</InlineFigures>
<Attachments>
<NoOfAttachments>0</NoOfAttachments>
</Attachments>
</Media>
</OrigData>
</GmsArticle>]]></plaintext></textgroup></pgraph></abstract></origdata></gmsarticle>